Hui Ling Ko
Impact in
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- Hepatitis C virus research 2
- Co-authors
- Ee Chee RenZiwei XiaoBei WangZakir HossainSafiah Mohamed AliChee Peng NgJianliang XuQi Zeng
- Journals
- Proceedings of the National Academy of Sciences (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal of Hepatology (1 paper)Biomolecules (1 paper)Cell Cycle (1 paper)
- Partner nations
- SingaporeUnited StatesJapan
In The Last Decade
Hui Ling Ko
10 papers receiving 623 citations
Peers
Comparison fields: 5 of 77
- Cell Biology 210
- Oncology 169
- Molecular Biology 369
- Immunology 98
- Physiology 13
Countries citing papers authored by Hui Ling Ko
This map shows the geographic impact of Hui Ling Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ling Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ling Ko more than expected).
Fields of papers citing papers by Hui Ling Ko
This network shows the impact of papers produced by Hui Ling Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ling Ko. The network helps show where Hui Ling Ko may publish in the future.
Co-authors
The 24 scholars most cited alongside Hui Ling Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 1 | |
| 5 | 2019 | 38 | |
| 6 | 2017 | 9 | |
| 7 | 2014 | 73 | |
| 8 | 2013 | 40 | |
| 9 | 2012 | 152 | |
| 10 | 2010 | 74 | |
| 11 | 2007 | 241 |
About Hui Ling Ko
Hui Ling Ko is a scholar working on Hepatology, Otorhinolaryngology, Physiology, Virology and Immunology, having authored 11 papers that have together received 633 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (2 papers), Adenosine and Purinergic Signaling (1 paper), Viral Infections and Immunology Research (1 paper), HIV Research and Treatment (1 paper), Cell death mechanisms and regulation (1 paper), Genetic Syndromes and Imprinting (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Cell Biology (210 citations), Oncology (169 citations), Molecular Biology (369 citations), Immunology (98 citations) and Physiology (13 citations). Hui Ling Ko has collaborated with scholars based in Singapore, United States and Japan. Frequent co-authors include Ee Chee Ren, Ziwei Xiao, Bei Wang, Zakir Hossain, Safiah Mohamed Ali, Chee Peng Ng, Jianliang Xu, Qi Zeng, Wanjin Hong and Sathivel Ponniah. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Radiation Oncology*Biology*Physics, Journal of Hepatology, Biomolecules and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.